Patent Assignment
Reel/Frame 073715/0409
U.S. Patent Security Agreement Supplement
Recorded: 2025-11-25
Pages: 8
Assignor
SALIX PHARMACEUTICALS, INC.
Executed: 2025-11-25
Assignee
JPMORGAN CHASE BANK, N.A.
10 S. DEARBORN ST., FLOOR L2, CHICAGO, ILLINOIS, 60603
Covered Properties
(4)
Solid Dispersion Forms of Rifaximin
Application:
18/958,759 →
Publication:
US 2025/0082616
Methods of Treating Hepatic Encephalopathy
Application:
19/096,880 →
Publication:
US 2025/0228828
Solid Dispersion Forms of Rifaximin
Application:
19/299,544 →
Publication:
US 2026/0014126
Solid Dispersion Forms of Rifaximin
Application:
19/299,563 →
Publication:
US 2025/0367175
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Mar 26, 2025
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 070629/0776 →
Second Lien Intellectual Property Security Agreement
Mar 26, 2025
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 070629/0798 →
Intellectual Property Security Agreement
Mar 26, 2025
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 070629/0756 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Security Interest
Oct 7, 2025
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 072495/0656 →
Assignment of Assignor's Interest
Nov 20, 2025
From: GOLDEN, PAM; KABIR, MOHAMMED A.
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 072971/0589 →
Assignment of Assignor's Interest
Nov 20, 2025
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 072971/0624 →
Security Interest
Mar 30, 2026
From: BAUSCH HEALTH IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 074223/0753 →